PET/CT imaging 2 h after injection of [18F]PSMA-1007 can lead to higher staging of prostate cancer than imaging after 1 h
Abstract Background [18F]PSMA-1007 is a prostate specific membrane antigen (PSMA) ligand for positron emission tomography (PET) imaging of prostate cancer. Current guidelines recommend imaging 90–120 min after injection but strong data about optimal timing is lacking. Our aim was to study whether im...
Kaydedildi:
| Asıl Yazarlar: | , , , , , |
|---|---|
| Materyal Türü: | Artigo |
| Dil: | Inglês |
| Baskı/Yayın Bilgisi: |
SpringerOpen
2023-05-01
|
| Seri Bilgileri: | European Journal of Hybrid Imaging |
| Konular: | |
| Online Erişim: | https://doi.org/10.1186/s41824-023-00167-4 |
| Etiketler: |
Etiket eklenmemiş, İlk siz ekleyin!
|